OPKO Health (NASDAQ:OPK) Rating Reiterated by HC Wainwright
OPKO Health (NASDAQ:OPK – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $3.00 price target on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 200.00% from the stock’s current price. Several […]
More Stories
Clearwater Paper Co. (NYSE:CLW) Short Interest Update
Clearwater Paper Co. (NYSE:CLW – Get Free Report) saw a large decrease in short interest in October. As of October...
GraniteShares 2x Long COIN Daily ETF (NASDAQ:CONL) Sees Significant Decrease in Short Interest
GraniteShares 2x Long COIN Daily ETF (NASDAQ:CONL – Get Free Report) was the target of a large decline in short...
B. Metzler seel. Sohn & Co. Holding AG Invests $14.08 Million in The Walt Disney Company (NYSE:DIS)
B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of The Walt Disney Company (NYSE:DIS...
PepsiCo, Inc. (NASDAQ:PEP) Shares Sold by Belmont Capital LLC
Belmont Capital LLC lowered its holdings in PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 72.5% during the third quarter, HoldingsChannel.com...
Cassaday & Co Wealth Management LLC Invests $213,000 in Salesforce, Inc. (NYSE:CRM)
Cassaday & Co Wealth Management LLC acquired a new stake in Salesforce, Inc. (NYSE:CRM – Free Report) during the 3rd...
Alexander & Baldwin, Inc. (NYSE:ALEX) Short Interest Update
Alexander & Baldwin, Inc. (NYSE:ALEX – Get Free Report) was the recipient of a significant decline in short interest in...